NCT02928107 is a NA clinical trial of Tele-HS in Hearing Loss, sponsored by Duke University.

Who is sponsoring NCT02928107?

NCT02928107 is sponsored by Duke University.

What drugs are being tested in NCT02928107?

Interventions in NCT02928107: Tele-HS, PCP encouragement.

What condition does NCT02928107 study?

NCT02928107 studies Hearing Loss, Geriatric Disorder.

Is NCT02928107 still recruiting?

NCT02928107 is currently completed. Last updated 9 November 2021.

Last reviewed 2021-11-09 · How we verify

NCT02928107

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Addressing Barriers to Adult Hearing Healthcare

Completed NA Last updated 9 November 2021

What this trial tests

NA trial testing Tele-HS in Hearing Loss in 1,146 participants. Completed in 27 August 2021.

Timeline

31 October 2016

Primary endpoint
27 August 2021

27 August 2021

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	1,146
Start date	31 October 2016
Primary completion	27 August 2021
Estimated completion	27 August 2021
Sites	6 locations across United States

Drugs / interventions tested

Tele-HS
PCP encouragement

Conditions studied

Hearing Loss — all drugs for Hearing Loss →
Geriatric Disorder — all drugs for Geriatric Disorder →

Sponsor

Duke University

Who can join

Adults 65 to 75, any sex, with Hearing Loss or Geriatric Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to develop evidence that can inform hearing health care best practices for adults between the ages of 65-75, and determine what level of involvement by the primary care practitioner (PCP) is required to inform and encourage adults age 65-75 to follow through with routine hearing screening. This study also aims to evaluate the accuracy of assessment of medical conditions for which the FDA requires physician evaluation and management prior to hearing aid fitting, and determine which medical conditions should require medical evaluation prior to hearing aid fitting. The results of this study should provide information to implement changes in health care policy to facilitate accessible and affordable hearing health care.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Comparative implementation-effectiveness of three strategies to perform hearing screening among older adults in primary care clinics: study design and protocol.
Bettger JP, Dolor RJ, Witsell DL, Dubno JR, et al · · 2020 · cited 8× · PMID 32393184 · DOI 10.1186/s12877-020-01576-x
A Pragmatic Clinical Trial of Hearing Screening in Primary Care Clinics: Effect of Setting and Provider Encouragement.
Smith SL, Francis HW, Witsell DL, Dubno JR, et al · · 2024 · cited 7× · PMID 37599396 · DOI 10.1097/aud.0000000000001418
A pragmatic clinical trial of hearing screening in primary care clinics: cost-effectiveness of hearing screening.
Dubno JR, Majumder P, Bettger JP, Dolor RJ, et al · · 2022 · cited 6× · PMID 35751122 · DOI 10.1186/s12962-022-00360-5
Hearing Screening in Older Adults in Primary Care Clinics: How the Effects of Setting and Provider Encouragement Differ by Patient Sex and Race.
West JS, Dubno JR, Francis HW, Smith SL. · · 2025 · cited 2× · PMID 39477819 · DOI 10.1097/aud.0000000000001604
Routine Hearing Screening for Older Adults in Primary Care: Insights of Patients and Clinic Personnel.
Silberberg M, Singh A, Prvu Bettger J, Smith SL, et al · · 2024 · cited 2× · PMID 39175188 · DOI 10.1093/geront/gnae107

Verify or expand the search:

Other recruiting trials for Hearing Loss

Currently open trials in the same condition.

NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02928107 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 9 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02928107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing